Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease.

Masoumeh Azimirad Abbas YadegarFatemeh GholamiShabnam ShahrokhHamid Asadzadeh AghdaeiGianluca IaniroHidekazu SuzukiGiovanni CammarotaMohammad Reza Zali

Published in: Journal of inflammation research (2020)

We demonstrated that FMT appears to be an effective, safe and rational therapeutic alternative for resolution of rCDI in patients with underlying IBD. Furthermore, we suggest implementing the CPE-producing C. perfringens testing in the screening of FMT donors.

Keyphrases

clostridium difficile
ulcerative colitis
stem cells
combination therapy
mesenchymal stem cells
replacement therapy